National Institute Drug Abuse

A primary mission of the National Institute on Drug Abuse is to ensure that science, not ideology or anecdote, forms the f oundation for our nation s drug abuse policies. This website is designed to ensure the rapid and effective tranfer of scientific data to policy makers, health care practitioners, and the general public. 

R. L. Hawks and C. N. Chiang, eds, Lrine Testing for Drugs of Abuse, NIDA Research Monograph 73, National Institute of Dmg Abuse, RockviUe, Md., 1986. 

CDC = Center for Disease Control DEA = Drug Enforcement Agency NIH = National Institute of Health NCHS = National Center for Health Statistics NIDA = National Institute on Drug Abuse IMS America = commercial source of drug use statistics... 

Community Epidemiology Workgroup Epidemiologic Trends in Drug Abuse Advanced Report (NIH Publ No 04-5363). Bethesda, MD, National Institute on Drug Abuse, December 2003... 

Johnston LD, O Malley PM, Bachman JG, et al Monitoring the Future National Results on Adolescent Drug Use Overview of Key Findings, 2003 (NIH Publ No 04—3506). Bethesda, MD National Institute on Drug Abuse, 2004 Jorda MA, Rayman N, Valk P, et al Identification, characterization, and function of a novel oncogene the peripheral cannabinoid receptor Cb2. Ann N Y Acad Sci 996 10-16, 2003... 

Preparation of this chapter supported by National Institute on Drug Abuse grants K05-DA00454 and P50-DA12762. 

Johnston LD, O Malley PM, Bachman JG, et al The National Survey Results on Drug Use from Monitoring the Future Smdy, 1975-1997. Rockville, MD, National Institute on Drug Abuse, 1998... 

GHB has been used both for legitimate clinical and chnical research purposes and for a range of iUicit purposes. It was marketed legally in the United States until 1990, when the U.S. Food and Drug Administration (FDA) banned its sale to consumers. Except for the one indication described later in this section, GHB is a Schedule I controlled substance without other FDA-approved indications. The FDA has also declared y-butyrolactone (GBL) as a List I chemical and 1,4-butanediol (1,4-BD) as a Class I health hazard, practically designating these GHB precursors, which are also industrial solvents, as illicit and unapproved new drugs (National Institute on Drug Abuse 2000). 

Sellers EM, Naranjo CA, Harrison M, et al Diazepam loading simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 34 822-826, 1983 Sharp CW Introduction to inhalant Abuse, in Inhalant Abuse A Volatile Research Agenda (NIDA Research Monograph 129). Edited by Sharp CW, Beuvais F, Spence R. Rockville, MD, National Institute on Drug Abuse, 1992, pp 1-10 Smelson DA, Losonczy MF, Davis CW, et al Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry 47 671-675, 2002... 

This work was supported by Grant GM 27256 from the National Institutes of Health and Grant DA 02507 from the National Institute of Drug Abuse. LL. is an American Cancer Society Research Professor of Biochemistry (Award PRP-21). H.V.V. is the recipient of a Research Career Award (5K6-AI-2372) from the National Institute of Allergy and Infectious Disease. We thank Dr. Y. Hirata of Meijo University for generous gifts of palytoxin isolated from Palythoa tuberculosa. We thank Dr. T. Yasumoto, Tohoku University, Sendai, Japan, for the maitotoxin preparation. We thank also Jeffrey A. Bessette and Nancy Worth for their technical assistance and Inez Zimmerman for preparation of the manuscript. 

Acknowledgment We gratefully acknowledge the support of the National Institute on Drug Abuse grant DA POl 19398. 

Acknowledgments The authors thank the National Institute of Health and National Institute of Drug Abuse for their continuous support (grants DA15014 DA19808). 

Preparation of this paper was supported by grant DA 01147 from the National Institute on Drug Abuse and contract no. 271-86-8113 from the National Institute on Drug Abuse. 

This work was supported in part by National Institute of Mental Health Research Scientist Development Award MH00188, National Institute on Drug Abuse Awards DA 02925 and DA 04398, and a Parkinson s Disease Summer Fellowship. 

National Institute on Drug Abuse and a grant from the Office of Naval... 

This work was supported by U.S. Public Health Service grants DA 00869 and DA 04222. The National Institute of Drug Abuse contributed the methamphetamine hydrochloride. MDMA, and MDA, NOVO Industrials is acknowledged for contributing GBR 12909. 

Anderson, G.M. Braun, G. Braun, U. Nichols, D.E. and Shulgin, A.T. Absolute configuration and psychotomimetic activity. In Barnett, G. Trsic, M. and Willette, R., eds. Quasar Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens. National Institute on Drug Abuse Research Monograph 22. Rockville, MD the Institute, 1978. pp. 8-15. 

Chief, Laboratory of Neurobiology Neuroscience Branch Addiction Research Center National Institute on Drug Abuse Baltimore, MD 21224... 

Kleven, M. Woolverton, W. Schuster, C. and Seiden, L. Behavioral and neurochemical effeets of repeated or continuous exposure to cocaine. In Harris, L.S., ed. Problems of Drug Dependence, 1987. National Institute on Drug Abuse Researeh Monograph 81. DHHS Pub. No. 

---